Time-restricted feeding linked to improvements in Crohn’s disease

Time-restricted feeding may improve metabolic and inflammatory markers in adults with Crohn’s disease, according to a randomized study published in Gastroenterology.

“Time-restricted feeding appears to be a feasible and potentially supportive adjunct strategy for patients with Crohn’s disease who are living with overweight, particularly when implemented in a structured, monitored way,” said lead author Natasha Haskey, RD, PhD, a research associate in biology at the University of British Columbia Okanagan. “Importantly, this was not presented as a replacement for medical therapy, but rather as a dietary strategy to complement standard care.”

In the study, investigators enrolled 35 adults with Crohn’s disease and overweight or obesity in a 12-week randomized controlled trial evaluating time-restricted feeding. Participants were randomly assigned either to a time-restricted feeding intervention, in which all meals were consumed within an 8-hour daily eating window followed by a 16-hour fast, or to continue their usual eating schedule. Twenty participants followed the time-restricted feeding protocol and 15 served as controls. Investigators assessed body composition, inflammatory markers, and clinical disease activity at baseline and after 12 weeks.

Compared with controls, patients in the intervention group experienced significant reductions in body mass index and visceral adiposity, along with improvements in disease activity measures over the course of the study. The findings also suggested reductions in systemic inflammatory markers among participants following the time-restricted eating pattern.

Interest in dietary approaches to inflammatory bowel disease has grown as researchers explore links between metabolic health and intestinal inflammation. While many nutrition studies focus on dietary composition, the Crohn’s disease trial examined whether the timing of food intake alone could influence clinical outcomes.

According to Dr. Haskey, one of the most notable aspects of the findings was that a relatively modest behavioral change appeared to produce measurable improvements in symptoms and disease activity. “A relatively simple change in the timing of meals, without a tightly controlled feeding protocol, appeared to be associated with meaningful signals of benefit, in particular, a reduction in symptoms, disease activity, and quality of life,” she said.

Investigators also observed changes in visceral adiposity, a metabolically active fat depot that has been associated with systemic inflammation and metabolic risk. “Those that received the fasting intervention were able to reduce visceral adiposity, a metabolically active fat depot associated with inflammation, suggesting that eating patterns may influence body composition in ways that could be relevant for inflammatory disease,” Dr. Haskey said.

Despite the encouraging findings, investigators noted that time-restricted feeding is not appropriate for all patients with Crohn’s disease. Nutritional status and disease stability should be considered before recommending dietary restriction. “In practice, time-restricted feeding should be used selectively under health care guidance, not as a universal recommendation,” Dr. Haskey said. “It is most appropriate for clinically stable patients who are well nourished, motivated, and able to meet their energy and protein needs within the eating window.”

Patients with Crohn’s disease frequently face nutritional challenges, including malnutrition and micronutrient deficiencies. “It should be approached cautiously because patients with Crohn’s disease may already be at nutrition risk of inadequate intake and nutrient deficiencies,” she added.

Crohn’s disease management has traditionally focused on pharmacologic therapies aimed at controlling inflammation and preventing complications. However, growing evidence suggests that metabolic factors — including obesity and visceral adiposity — may influence inflammatory pathways and disease activity. Larger studies will be needed to confirm the findings and determine whether metabolic improvements translate into sustained clinical benefit.

Investigators reported having no conflicts of interest.

Key Takeaways

• A 12-week randomized controlled trial evaluated time-restricted feeding in adults with Crohn’s disease and overweight or obesity.

• Thirty-five participants were enrolled; 20 followed time-restricted feeding and 15 served as controls.

• The intervention required an 8-hour daily eating window followed by a 16-hour fast.

• Time-restricted feeding was associated with significant reductions in body mass index and visceral adiposity and improvements in disease activity measures.

• The strategy was studied as an adjunct to standard medical therapy, not a replacement.

• Investigators say the approach may be most appropriate for clinically stable, well-nourished patients under medical guidance.

• Larger studies are needed to determine whether metabolic improvements translate into sustained disease control.